Bristol-Myers Squibb tops Q4 expectations, reports strong anemia drug sales
Go back to Bristol-Myers Squibb tops Q4 expectations, reports strong anemia drug sales| Bristol-Myers Squibb (NYSE: BMY) | Delayed: 55.57 +0.87 (1.59%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $54.70 | 52 Week High | $77.12 | |||
| Open | $55.39 | 52 Week Low | $49.03 | |||
| Day High | $55.67 | P/E | 36.08 | |||
| Day Low | $54.96 | EPS | $1.54 | |||
| Volume | 2,673,825 | |||||
